🔗 Permalink

Inventor profile of:

Kirk JOHNSON

City:

Moraga, California

Country:

United States

Published Applications:

Last publication date:

2017-02-09

Top Assignees for applications by Kirk JOHNSON

The entities that hold a legal rights for patent applications filed by inventor JOHNSON Kirk:

Chiron Corporation 4 Emeryville, CA United States
Novartis Vaccines and Diagnostics, Inc. 3 Emeryville, CA United States
Baxter Healthcare S.A. 1 Glattpark, Switzerland
G.D. SEARLE LLC 1 New York, NY United States
G. D. Searle LLC 1 New York, NY United States
XOMA (US) LLC 1 Emeryville, CA United States
BAXTER INTERNATIONAL INC. 1 Deerfield, IL United States
G. D. Searle & Co. 1 Skokie, IL United States
MediciNova, Inc. 1 La Jolla, CA United States
G. D. Searle, LLC 1 St. Louis, MO United States

Recent patent applications by JOHNSON Kirk

Kirk JOHNSON from Moraga, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2017-02-09

US20170037135A1

Chemistry; metallurgy

Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia

#2 | 2015-02-19

US20150051191A1

Human necessities

TREATMENT OF ALCOHOLISM USING IBUDILAST

#3 | 2010-06-10

US20100144667A1

Chemistry; metallurgy

Methods for fucoidan purification from sea weed extracts

#4 | 2009-08-27

US20090215695A1

Human necessities

REGULATION OF CYTOKINE SYNTHESIS AND RELEASE

#5 | 2008-11-13

US20080281084A1

Chemistry; metallurgy

Formulation, Solubilization, Purification, and Refolding of Tissue Factor Pathway Inhibitor

#6 | 2008-02-21

US20080045452A1

Human necessities

Regulation of Cytokine Synthesis and Release

#7 | 2007-01-04

US20070004743A1

Human necessities

Intranasal administration of mc4-r agonists

#8 | 2006-06-15

US20060128947A1

Chemistry; metallurgy

Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor

#9 | 2006-05-16

US9949035

Inhibitors of glycogen synthase kinase 3

#10 | 2006-04-27

US20060089369A1

Chemistry; metallurgy

Inhibitors of glycogen synthase kinase 3

#11 | 2006-04-04

US9996588

Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor

InventorID:

1073384 ⎘